Optimized protocols to determine PD-L1 expression on tumor tissue and cytology samples from non-small cell lung cancer (NSCLC) patients using the 22C3 antibody with various immunohistochemistry (IHC) autostainers
XX
BSO - Titre
1178POptimized protocols to determine PD-L1 expression on tumor tissue and cytology samples from non-small cell lung cancer (NSCLC) patients using the 22C3 antibody with various immunohistochemistry (IHC) autostainers